Spectrum of disease in familial focal and segmental glomerulosclerosis
| Autor: | Margaret A. Pericak-Vance, L. Darryl Quarles, M. Bembe, Peter J. Conlon, Kelvin Lynn, Segmental Glomerulosclerosis, David N. Howell, Michelle P. Winn, Marcy C. Speer |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Adult
Male Pathology medicine.medical_specialty urologic and male genital diseases Gastroenterology Focal segmental glomerulosclerosis renal disease Internal medicine Biopsy medicine Humans genetics Kidney transplantation Aged inherited FSGS Proteinuria medicine.diagnostic_test Glomerulosclerosis Focal Segmental business.industry Glomerulosclerosis Middle Aged medicine.disease Kidney Transplantation female genital diseases and pregnancy complications Transplantation FSGS Nephrology Kidney Failure Chronic Female Renal biopsy medicine.symptom business glomerulonephritis Kidney disease |
| Zdroj: | Kidney International. 56:1863-1871 |
| ISSN: | 0085-2538 |
| DOI: | 10.1046/j.1523-1755.1999.00727.x |
| Popis: | Spectrum of disease in familial focal and segmental glomerulosclerosis Background Focal segmental glomerulosclerosis (FSGS) is the underlying pathologic entity in 5% of adults and 20% of children with end-stage renal disease (ESRD). FSGS is generally considered to be sporadic in origin. Methods Recently, we identified 60 families involving 190 individuals with familial FSGS, providing evidence for a subset of families in which a genetic form is segregating. Each family had at least one member with renal biopsy-confirmed FSGS and at least one other member with either renal biopsy-confirmed FSGS or ESRD. Results Twenty-six families had individuals affected in more than one generation [multigeneration (MG)], and the remaining 34 families had only a single generation (SG) affected. There was equal representation of males and females among affected individuals. Ten percent of MG families were African American, and 52% of SG families were African American. The mean age of presentation was significantly higher in the MG families (32.5 ± 14.6 years) compared with the SG families (20.1 ± 12.1 years, P = 0.0001). SG cases had higher levels of proteinuria at presentation (7.0 ± 5.6 g/24 hr, compared with 3.8 ± 3.4 g/24 hr, for the MG families, P = 0.002). On renal biopsy, tubulointerstitial damage was more severe in patients in the SG families than in the MG families; however, the level of glomerular damage did not differ between these groups. Fifty percent of the patients had progressed to ESRD by the age of 30 years. Variables measured at presentation that were independently associated with poor renal survival were decreased age, increased serum creatinine, and increased urinary protein excretion. Forty-one patients underwent successful renal transplantation, with a 10-year graft survival rate of 62%. One patient developed clinical and biopsy evidence of recurrence of FSGS in the allograft. Conclusion These data confirm the existence of a non-Alport's form of hereditary glomerulonephritis, which has a morphological pattern of FSGS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|